Paper Review Records
All Paper Review Records
30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
240
days
Improving Safety Reporting: Putting the Question First and Choosing the Right Estimator for the Incidence of Treatment‐Emergent Adverse Events
Authors
Stefan Englert; Zoe Craig; Nicolas Sauvageot; Valentine Jehl; Anirban Mitra; Jane Gilbert; Lilla Di Scala; Leen SlaetsShow moreShow less
Affiliations
1. Statistical Modeling & Methodology Johnson & Johnson Neuss Germany; 2. Statistics & Decision Sciences Johnson & Johnson High Wycombe UK; 3. Statistics & Decision Sciences Johnson & Johnson Allschwil Switzerland; 4. Novartis Basel Switzerland; 5. Statistics & Decision Sciences Johnson & Johnson Hyderabad India; 6. Statistics & Decision Sciences Johnson & Johnson Beerse BelgiumShow moreShow less
205
days
A New Optimal Cut‐Points Selection Method for Diseases With Multiple Ordinal Stages and Its Confidence Interval Estimation
Authors
Nan An; Lili TianShow moreShow less
Affiliations
1. Department of Biostatistics University at Buffalo Buffalo New York USAShow moreShow less
274
days
Advancing Drug Development Through Bayesian Approaches: Insights Drawn From Practical Experience in Pharmaceutical R&D
Authors
Telba Irony; Tobias Mielke; Fredrik Ohrn; Vladimir DragalinShow moreShow less
Affiliations
1. Quantitative Sciences and Clinical Pharmacology Johnson & Johnson, Innovative Medicine Spring House Pennsylvania USAShow moreShow less
485
days
Inverse Probability of Censoring Weights for Single and Competing Events Survival Analyses With Dependent Censoring
Authors
Emily C. Zabor; Anne A. EatonShow moreShow less
Affiliations
1. Department of Quantitative Health Sciences Cleveland Clinic Cleveland Ohio USA; 2. Division of Biostatistics and Health Data Science University of Minnesota Minneapolis Minnesota USAShow moreShow less
362
days
Estimands for Randomized Discontinuation Designs in Oncology
Authors
Ayon Mukherjee; Oleksandr Sverdlov; Yu DengShow moreShow less
Affiliations
1. Population Health Sciences Institute, Newcastle University Newcastle UK; 2. Quantitative Sciences, Alnylam Pharmaceuticals Cambridge Massachusetts USA; 3. Biostatistics, Genentech Inc. South San Francisco California USAShow moreShow less
422
days
Estimation of Treatment Effect in Clinical Trials of Continuous Endpoints With Retrieved Dropouts
Authors
Myeongjong Kang; Sangyoon YiShow moreShow less
Affiliations
1. Merck & Co. Inc. Rahway New Jersey USA; 2. Department of Statistics Oklahoma State University Stillwater Oklahoma USAShow moreShow less
FAQ
How long does PHARMACEUTICAL STATISTICS take to review a manuscript?
As of 2026-11-18, CrushSCI has 30 complete review records for PHARMACEUTICAL STATISTICS. The fastest paper went from submission to acceptance in 109 days (A Cautionary Note on Regional Consistency Evaluation With Multiple Primary Endpoints in Multiregional Clinical Trials, received 2026-04-13, accepted 2026-07-31); the slowest took 521 days. The average is 292.1 days and the median is 255.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
